Key result
Transfemoral TAVI achieves durable hemodynamic success and NYHA class I status in quadricuspid aortic valve.
Why the study?
Transcatheter aortic valve implantation (TAVI) is emerging as a less invasive alternative to surgery for severe aortic stenosis in high-risk patients with quadricuspid aortic valve (QAV), a rare congenital anomaly.
Does transfemoral transcatheter aortic valve implantation improve valve function and symptoms in a high-risk patient with severe aortic stenosis on a quadricuspid aortic valve?
Case Report (n=1)
No
Does transfemoral transcatheter aortic valve implantation improve valve function and symptoms in a high-risk patient with severe aortic stenosis on a quadricuspid aortic valve?
This case report demonstrates that transfemoral TAVI using a balloon-expandable valve is a feasible and effective alternative to surgery in high-risk patients with severe aortic stenosis on a rare quadricuspid aortic valve.
BACKGROUND: Quadricuspid aortic valve (QAV) is a rare congenital anomaly with an incidence of 0.006% to 0.05%. It often leads to aortic stenosis or regurgitation due to progressive fibrosis and calcification. While surgical aortic valve replacement has been the standard treatment, transcatheter aortic valve implantation (TAVI) is emerging as a less invasive alternative for high-risk patients. CASE SUMMARY: An 84-year-old woman with ischemic cardiomyopathy and heart failure presented with severe aortic stenosis on a calcified QAV. Given her high surgical risk (EuroSCORE II: 9.69), she underwent successful transfemoral TAVI with a 23-mm Edwards Sapien III Ultra valve. Postoperatively, she developed a left bundle branch block requiring an upgrade to cardiac resynchronization therapy with defibrillator. At the 1-year follow-up, she remained minimally symptomatic with excellent valve function. TAKE-HOME MESSAGE: TAVI is a feasible and effective option for treating severe aortic stenosis in patients with QAV, offering a viable alternative to surgery in high-risk cases.
No takes yet. Share an insight, caveat, or question.
Cook et al. (2026) conducted a case report in Severe aortic stenosis on a calcified quadricuspid aortic valve (QAV) with heart failure with reduced ejection fraction (HFrEF) (n=1). Transfemoral transcatheter aortic valve implantation (TAVI) with a 23-mm Edwards Sapien III Ultra balloon-expandable valve was evaluated on Procedural success, valve function, and clinical symptom status (NYHA class).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: